Many cancer cohorts collect biospecimens, but these samples are usually collected infrequently, making it impossible to correlate these biomarkers with tumor development.
Given funding, OncoPharmacia is ready to go full blast to the moon to create a better cancer chemotherapeutic to attack resistant cancer cells while providing a novel self-destruction mechanism in normal cells that will reduce human suffering.
Identification of new small molecules that have the potential to improve the prognosis of patients with malignant brain cancers will represent a novel approach to cancer treatment. Brain penetrable kinase inhibitor represent a potential solution.
The ideas presented in this research idea are aimed better understanding and treating metastatic cancer across all types of cancer.
Cancer is viewed as a disease of overproliferation, but 90% of patients die due to metastasis. The Achilles heel of metastasis may be its lack of proliferation, presenting a unique opportunity to target this lethal aspect of cancer progression.
Metastatic cells must find a suitable microenvironment to colonize and proliferate in distant organs. Circulating tumor generated exosomes generated might be playing an important role in generating a pre-metastatic niche in the target organs.
Tumor microscopic invasion is not isotropic. Certain microenvironment may be more suitable for the invasion and in turn, the tumor invasion may change the microenvironment. To be able to identify these microenvironment will lead to better treatment.
Lack of knowledge on post-treatment tumor evolution is necessary to predict genetic abnormalities (that tumor will acquire), so dynamically optimized treatment regimens could be given. Emphasis for kinetic over snapshot data collection is needed.
Society of Gynecologic Oncology recommends a coordinated multidisciplinary effort to accelerate drug development against mutated p53 in cancer.
One of the key sources of morbidity for radiation related dysphagia is the irradiation of the retropharyngeal nodes. No existing data. and TORS surgeons can sample retropharyngeal nodes.
With new targeted drugs, revised treatment schedules offer new ways to optimize cancer treatments. New bio-mathematical optimization methods can thus fully utilize combined treatment approaches. Models can be patient-specific when based on imaging.
The relations between cancer and the nervous system and their impact on tumor progression are generally underestimated and specific resources should be addressed towards their study.
The presence of cancer (early and advanced) seems to have effects upon functional status that vary based on both tumor and patient characteristics. A better understanding of why this occurs is needed.
The aim of this project is to develop a next-generation medical device able to capture and eliminate most if not all the circulating tumor cells (CTCs) during their travel through the circulatory system of a cancer patient.
There are precious few methods to catalogue the tumor microenvironment (TME), especially in living systems. Cytotyping the TME is essential to understanding its role in tumor progression.